Vitamin D supplementation not supported to treat first-episode psychosis
1. The DFEND double-blind, randomized controlled trial revealed that Vitamin D supplementation led to no improvements in clinical outcomes at ...
Tag: Psychosis
Pimavanserin continuation lower psychosis relapse risk in patient with dementia-related psychosis
1. Pimavanserin was shown to lead to a lower risk of relapse of psychosis in patients who had an initial ...
Xanomeline-trospium treatment showed improvement in patients with schizophrenia
1. Xanomeline-trospium treatment showed a greater reduction in the degree of psychosis in patients with schizophrenia compared to placebo. 2. ...
#VisualAbstract: Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission
1. In this randomized controlled trial, patients with Major depressive disorder with psychotic features who were stable on olanzapine and ...
Olanzapine discontinuation leads to higher relapse in depression with psychosis
1. In this randomized controlled trial, patients with Major depressive disorder with psychotic features who were stable on olanzapine and ...
Quick Take: Association of Hippocampal Glutamate Levels with Adverse Outcomes in Individuals at Clinical High Risk for Psychosis
Neural hyperactivity in the hippocampus has been shown to play a role in psychosis, as it has been thought to ...
